SCHEMBL19081545

SCHEMBL19081545

c1cc(-c2ccc3oc4c(ccc5oc6c7ccccc7ccc6c54)c3c2)cc(-c2c3ccccc3c(-c3cccc4ccccc34)c3ccccc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 13/20 0.36
CYP1B1 Q16678 12/20 0.36
CYP1A2 P05177 12/20 0.36
PRKDC P78527 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 2/20 0.36
ABCG2 Q9UNQ0 2/20 0.36
PDE5A O76074 1/20 0.36
TP53 P04637 1/20 0.36
ABCB1 P08183 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2B6 P20813 1/20 0.36
TACR2 P21452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16067815 0.95 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19081526 0.94 ALOX5 (0.36) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL22868287 0.94 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19081552 0.93 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19081551 0.93 PLA2G2A (0.38) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19081546 0.92 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL17945594 0.92 ALOX5 (0.39) PRKDCKDM4EALDH1A1MAPTHPGD
SCHEMBL27335478 0.92 ALOX5 (0.40) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL16068020 0.92 ALOX5 (0.41) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19081549 0.91 AHR (0.36) CYP1A1CYP1A2MAPTABCG2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.